Response to Letter to the Editor From Banerjee and Mondal: "Management of Hyperglycemia in Hospitalized Adult Patients in Noncritical Care Settings: An Endocrine Society Clinical Practice Guideline"

Affiliations

¹ University of Pittsburgh, Division of Endocrinology, Diabetes and Metabolism, Pittsburgh, PA 15213, Bethesda, MD 20892,USA.
² National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
³ University of Nebraska Medical Center, Division of Diabetes, Endocrinology and Metabolism, Omaha, NE 68198, USA.
⁴ University of Washington Diabetes Institute, Seattle, WA 98109, USA.
⁵ Division of Diabetes, Endocrinology and Hypertension, Brigham and Women's Hospital, and Harvard Medical School, Boston MA, USA.
⁶ Mayo Clinic Evidence-Based Practice Center, Rochester, MN 55905, USA.
⁷ Division of Internal Medicine and Geriatrics, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.
⁸ University of California, Department of Medicine, Division of Endocrinology and Metabolism, CA 94143, San Francisco.

Comment

Mary T Korytkowski et al. J Clin Endocrinol Metab. 2022.

. 2022 Sep 28;107(10):e4276-e4277.

doi: 10.1210/clinem/dgac479.

¹ University of Pittsburgh, Division of Endocrinology, Diabetes and Metabolism, Pittsburgh, PA 15213, Bethesda, MD 20892,USA.
² National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
³ University of Nebraska Medical Center, Division of Diabetes, Endocrinology and Metabolism, Omaha, NE 68198, USA.
⁴ University of Washington Diabetes Institute, Seattle, WA 98109, USA.
⁵ Division of Diabetes, Endocrinology and Hypertension, Brigham and Women's Hospital, and Harvard Medical School, Boston MA, USA.
⁶ Mayo Clinic Evidence-Based Practice Center, Rochester, MN 55905, USA.
⁷ Division of Internal Medicine and Geriatrics, Cleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.
⁸ University of California, Department of Medicine, Division of Endocrinology and Metabolism, CA 94143, San Francisco.

No abstract available

Comment on

Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, Luger A, McDonnell ME, Murad MH, Nielsen C, Pegg C, Rushakoff RJ, Santesso N, Umpierrez GE. Korytkowski MT, et al. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-2128. doi: 10.1210/clinem/dgac278. J Clin Endocrinol Metab. 2022. PMID: 35690958 Free PMC article.
Letter to the Editor from Banerjee and Mondal: "Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline".
Banerjee M, Mondal S. Banerjee M, et al. J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4272-e4273. doi: 10.1210/clinem/dgac478. J Clin Endocrinol Metab. 2022. PMID: 35962775 No abstract available.

1. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. . Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2022;107(8):2101-2128. - PMC - PubMed
1. Banerjee M, Mondal S. Letter to the Editor from Banerjee and Mondal: “Management of hyperglycemia in hospitalized patients in noncritical care settings: an Endocrine Society clinical practice guideline”. J Clin Endocrinol Metab. Published online Month xx, 2022. - PubMed
1. Fayfman M, Galindo RJ, Rubin DJ, et al. . A Randomized controlled trial on the safety and efficacy of exenatide therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes. Diabetes Care. 2019;42(3):450-456. - PMC - PubMed
1. Kaneko S, Ueda Y, Tahara Y. GLP1 Receptor agonist liraglutide is an effective therapeutic option for perioperative glycemic control in type 2 diabetes within enhanced recovery after surgery (ERAS) protocols. Eur Surg Res. 2018;59(5-6):349-360. - PubMed
1. Galindo RJ, Dhatariya K, Gomez-Peralta F, et al. . Safety and efficacy of inpatient diabetes management with non-insulin agents: an overview of international practices. Curr Diab Re 2022;22(6):237-246. - PMC - PubMed